| Announce Date | 02/03/2026 |
| EPS Normalized Actual | $1.23 (Beat by $0.14) |
| EPS GAAP Actual | $1.23 (Beat by $0.14) |
| Revenue Actual | $0.311455B |
| Revenue Surprise | Beat by $311.455M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $1.01657 |
| EPS GAAP Estimate | $1.01657 |
| Revenue Estimate | $0.332079467B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 4.62 | 9.34 | 4.58426 | 4.65032 | 1 |
| Dec 2026 | 4.28622 | 10.07 | 4.17244 | 4.4 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.11 | 0.12302 | 0.311455B | 0.6% | -2.04M |
| FQ2 2025 (Jun 2025) | 1.12 | 0.15764 | 0.30383B | 2.37% | -14M |
| FQ1 2025 (Mar 2025) | 1.09 | 1.09 | 0.306776B | 100% | 306.78M |
| FQ4 2024 (Dec 2024) | 1.06 | 1.06 | 0B | NAN% | 0M |
| FQ3 2024 (Sep 2024) | 1.16 | 1.16 | 0.309588B | 100% | 309.59M |
| FQ1 2019 (Mar 2019) | 0 | 0 | 0.229345B | 100% | 229.35M |
| FQ2 2019 (Jun 2019) | 0 | 0 | 0.229345B | 100% | 229.35M |
| FQ3 2019 (Sep 2019) | 0 | 0 | 0.250676B | 100% | 250.68M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
1.01657
Consensus Revenue Estimates
0.332079467B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.28635 | -- | 1.26273 | 1.30367 | 1 |
| FQ3 2027 (Sep 2027) | 1.28358 | -- | 1.26002 | 1.30086 | 1 |
| FQ2 2027 (Jun 2027) | 1.28993 | -- | 1.26625 | 1.3073 | 1 |
| FQ1 2027 (Mar 2027) | 1.23877 | -- | 1.21603 | 1.25545 | 1 |
| FQ4 2026 (Oct 2026) | 1.05368 | -- | 1.04995 | 1.05725 | 0 |
| FQ3 2026 (Jul 2026) | 1.05293 | -5.42 | 1.0492 | 1.0565 | 0 |
| FQ2 2026 (Jun 2026) | 1.05752 | -5.91 | 1.03479 | 1.0703 | 1 |
| FQ1 2026 (Mar 2026) | 1.01657 | -7.22 | 0.99472 | 1.02886 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.34B | -- | 0.34B | 0.34B | 1 |
| FQ3 2027 (Sep 2027) | 0.34B | -- | 0.33B | 0.34B | 1 |
| FQ2 2027 (Jun 2027) | 0.33B | -- | 0.33B | 0.33B | 1 |
| FQ1 2027 (Mar 2027) | 0.33B | -- | 0.32B | 0.33B | 1 |
| FQ4 2026 (Oct 2026) | 0.33B | -- | 0.33B | 0.34B | 0 |
| FQ3 2026 (Jul 2026) | 0.33B | 5.45 | 0.33B | 0.33B | 0 |
| FQ2 2026 (Jun 2026) | 0.34B | 9.64 | 0.33B | 0.34B | 1 |
| FQ1 2026 (Mar 2026) | 0.33B | 7.62 | 0.33B | 0.34B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
0
EPS # of in-lines
3
Revenue # of Beats
5
Revenue # of Misses
2
Revenue # of in-lines
1
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.98698 | 1.11 | 0.12302 | 11.08% |
| FQ2 2025 (Jun 2025) | 0.96236 | 1.12 | 0.15764 | 14.08% |
| FQ1 2025 (Mar 2025) | 1.09 | 1.09 | 100% | |
| FQ4 2024 (Dec 2024) | 1.06 | 1.06 | 100% | |
| FQ3 2024 (Sep 2024) | 1.16 | 1.16 | 100% | |
| FQ1 2019 (Mar 2019) | 0 | 0 | NAN% | |
| FQ2 2019 (Jun 2019) | 0 | 0 | NAN% | |
| FQ3 2019 (Sep 2019) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.31B | $0.31B | $-2.04M | -0.66% |
| FQ2 2025 (Jun 2025) | $0.32B | $0.3B | $-14M | -4.61% |
| FQ1 2025 (Mar 2025) | $0B | $0.31B | $306.78M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0B | $0M | NAN% |
| FQ3 2024 (Sep 2024) | $0B | $0.31B | $309.59M | 100% |
| FQ1 2019 (Mar 2019) | $0B | $0.23B | $229.35M | 100% |
| FQ2 2019 (Jun 2019) | $0B | $0.23B | $229.35M | 100% |
| FQ3 2019 (Sep 2019) | $0B | $0.25B | $250.68M | 100% |